News Archives
- 2011-12-12 - New Insight Into Drug Action in Multiple Myeloma -- Medscape Today News
- 2011-12-12 - Peptide 'cocktail' elicits immune response to multiple myeloma -- EurekAlert
- 2011-12-12 - Phase II Study Evaluates Clinical Benefit of Pomalidomide in Heavily Pre-Treated Patients with Multiple Myeloma -- Business Wire
- 2011-12-11 - Onyx Pharmaceuticals Provides Update on Carfilzomib at 53rd American Society of Hematology Annual Meeting -- PR Newswire
- 2011-12-11 - ASH 2011 Multiple Myeloma Update – Day One -- The Myeloma Beacon
- 2011-12-11 - ARRY-520 Demonstrates Durable Single-Agent Activity in Patients with Advanced Multiple Myeloma -- News Wire
- 2011-12-11 - Beacon Breaking News – Carfilzomib To Get Standard, Not Priority, FDA Review -- The Myeloma Beacon
- 2011-12-10 - Second-Line Bortezomib + Dexamethasone Active in Patients with Multiple Myeloma -- Monthly Prescriber Reference
- 2011-12-10 - Addition of Bortezomib to Thalidomide-Dexamethasone as Post-ASCT Consolidation Therapy Significantly Increases Response and PFS in Multiple Myeloma -- MPR
- 2011-12-10 - Sarah Cannon Research Institute Presents Findings of Blood Cancer Clinical Trials at National Conference -- Market Watch/Business Wire
- 2011-12-05 - Keryx Biopharmaceuticals Announces Upcoming Presentations on KRX-0401 (Perifosine) at 53rd Annual Meeting of American Society of Hematology -- PR Newswire
- 2011-12-05 - CIBD: Activin A May Be Key in Myeloma Bone Disease -- Medpage Today
- 2011-12-02 - Salvage transplant safe, feasible for multiple myeloma -- Medpage Today
- 2011-11-30 - Breaking News: Multiple Myeloma - First Risk Genes Discovered-- Medical News Today
- 2011-11-29 - Severe Comorbidity Doubles Death Risk in Multiple Myeloma -- Oncology Report Digital Network